Search for: "RANBAXY LABORATORIES INC."
Results 1 - 20
of 75
Sort by Relevance
|
Sort by Date
20 Feb 2024, 7:16 am
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India’s Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor. [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
16 Apr 2018, 2:48 pm
Ranbaxy Laboratories Ltd., Ranbaxy soughtto limit a claim depicting a specific three-dimensionalorientation to a racemic mixture. 457 F.3d 1284, 1288–89(Fed. [read post]
25 Oct 2014, 9:01 pm
., Inc. v. [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
20 Feb 2014, 9:39 am
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
18 Feb 2014, 12:43 pm
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
2 Jan 2014, 10:45 pm
For details, see Ranbaxy. [read post]
10 Oct 2013, 8:42 am
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
30 Sep 2013, 8:12 am
Forest Laboratories, Inc. [read post]
21 Sep 2013, 6:55 pm
The Medicare fraud lawsuit is accusing LabCorp. of billing Medicaid fees way over what Premier Inc. purchasing collective members were charged. [read post]
3 Jun 2013, 8:38 am
Next up: another pharmaceutical company, Ranbaxy Laboratories, Ltd. [read post]
21 May 2013, 2:26 pm
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
13 May 2013, 7:58 am
Ranbaxy Laboratories, Ltd., et al. , Case No. [read post]
3 Mar 2013, 12:06 pm
Patil 337/DELNP/2003 LANXESS DEUTSCHLAND GMBH Granted Dr.Rajesh Dixit 4069/DELNP/2006 RANBAXY LABORATORIES LIMITED Withdrawn Hardev Karar 106/DELNP/2008 ALFA WASSERMANN S. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.'s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. [read post]
29 Aug 2012, 10:09 pm
., Inc. [read post]
15 Aug 2012, 11:02 am
District Court for the District of Columbia by Watson Laboratories, Inc. [read post]
